We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > osteoarthritis drug

News List

UK biotech gets grant for further trial of osteoarthritis drug pharmaphorum
February 21, 2019
UK biotech AKL Research and Development (AKLRD) has received a grant from a UK government-backed innovation body to develop its potentially “game changing” osteoarthritis drug.
Regeneron halts high doses of phase 3 osteoarthritis drug fasinumab amid risk-benefit concerns fiercebiotech
May 04, 2018
Regeneron has halted the higher-dose arms of its phase 3 fasinumab trials on the recommendation of a data monitoring committee. The committee made the call after assessing the risk-benefit profile of the osteoarthritis regimens based on data generated to